derivatives and risk management
the zinn company plans to issue $10,000,000 of 20-year bonds in june to help finance a new research and development laboratory. the bonds will pay interest semi- annually. it is now november, and the current cost of debt to the high-risk biotech company is 11 %. however, the firm's financial manager is concerned that interest rates will climb even higher in coming months.
Price Type: Negotiable
Total Proposals: 6
1 Current viewersl
14 Total views
Proposals Reputation Price offered
- 547 Jobs 386 Reviews $0 in 0 Day